A toolbox for Herpesvirus miRNA research: Construction of a complete set of KSHV miRNA Deletion Mutants

Viruses

Volumn 8, Issue 2, 2016, Pages

  Jain, Vaibhav ^a   Plaisance Bonstaff, Karlie ^a   Sangani, Rajnikumar ^a   Lanier, Curtis ^a   Dolce, Alexander ^a   Hu, Jianhong ^a   Brulois, Kevin ^b   Haecker, Irina ^a,d   Turner, Peter ^a   Renne, Rolf ^a,c   Krueger, Brian ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Bacmid; Human herpesvirus 8; KSHV; MiRNA

Indexed keywords

MICRORNA; VIRUS RNA;

ARTICLE; CARCINOGENESIS; ENDOTHELIUM CELL; ESCHERICHIA COLI; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS GENOME; GENE DELETION; GENETICS; KAPOSI SARCOMA; METABOLISM; VIROLOGY;

HERPESVIRUS 8, HUMAN; HUMANS; MICRORNAS; RNA, VIRAL; SARCOMA, KAPOSI; SEQUENCE DELETION;

EID: 85006741921     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/V8020054     Document Type: Article

References (39)

1. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J. W.; Knowles, D.M. Kaposi1s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332, 1186–1191. [CrossRef] [PubMed]
2. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi1s sarcoma. Science 1994, 266, 1865–1869. [CrossRef] [PubMed]
3. Soulier, J.; Grollet, L.; Oksenhendler, E.; Cacoub, P.; Cazals-Hatem, D.; Babinet, P.; d’Agay, M.F.; Clauvel, J.P.; Raphael, M.; Degos, L. et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman1s disease. Blood 1995, 86, 1276–1280. [PubMed]
4. Speck, S.H.; Ganem, D. Viral latency and its regulation: Lessons from the gamma-herpesviruses. Cell Host Microbe 2010, 8, 100–115. [CrossRef] [PubMed]
5. Ambros, V. The functions of animal microRNAs. Nature 2004, 431, 350–355. [CrossRef] [PubMed]
6. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233. [CrossRef] [PubMed]
7. Pfeffer, S.; Zavolan, M.; Grasser, F.A.; Chien, M.; Russo, J.J.; Ju, J.; John, B.; Enright, A.J.; Marks, D.; Sander, C. et al. Identification of virus-encoded microRNAs. Science 2004, 304, 734–736. [CrossRef] [PubMed]
8. Cai, X.; Lu, S.; Zhang, Z.; Gonzalez, C.M.; Damania, B.; Cullen, B.R. Kaposi1s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. USA 2005, 102, 5570–5575. [CrossRef] [PubMed]
9. Grundhoff, A.; Sullivan, C.S.; Ganem, D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12, 733–750. [CrossRef] [PubMed]
10. Pfeffer, S.; Sewer, A.; Lagos-Quintana, M.; Sheridan, R.; Sander, C.; Grasser, F.A.; van Dyk, L.F.; Ho, C.K.; Shuman, S.; Chien, M. et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2, 269–276. [CrossRef] [PubMed]
11. Samols, M.A.; Hu, J.; Skalsky, R.L.; Renne, R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi1s sarcoma-associated herpesvirus. J. Virol. 2005, 79, 9301–9305. [CrossRef] [PubMed]
12. Umbach, J.L.; Cullen, B.R. In-depth analysis of Kaposi1s sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 2010, 84, 695–703. [CrossRef] [PubMed]
13. Skalsky, R.L.; Cullen, B.R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 2010, 64, 123–141. [CrossRef] [PubMed]
14. Zhu, Y.; Haecker, I.; Yang, Y.; Gao, S.-J.; Renne, R.-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 2013, 3, 266–275. [CrossRef] [PubMed]
15. Gottwein, E.; Corcoran, D.L.; Mukherjee, N.; Skalsky, R.L.; Hafner, M.; Nusbaum, J.D.; Shamulailatpam, P.; Love, C.L.; Dave, S.S.; Tuschl, T. et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 2011, 10, 515–526. [CrossRef] [PubMed]
16. Haecker, I.; Gay, L.A.; Yang, Y.; Hu, J.; Morse, A.M.; McIntyre, L.; Renne, R. Ago-HITS-CLIP expands understanding of Kaposi’s sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 2012, 8, e1002884. [CrossRef] [PubMed]
17. Haecker, I.; Renne, R. HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis. Crit. Rev. Eukaryot. Gene Expr. 2014, 24, 101–116. [CrossRef] [PubMed]
18. Riley, K.J.; Rabinowitz, G.S.; Yario, T.A.; Luna, J.M.; Darnell, R.B.; Steitz, J.A. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012, 31, 2207–2221. [CrossRef] [PubMed]
19. Brulois, K.; Toth, Z.; Wong, L.-Y.; Feng, P.; Gao, S.-J.; Ensser, A.; Jung, J.U. Kaposi’s sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication. J. Virol. 2014, 88, 9335–9349. [CrossRef] [PubMed]
20. Brulois, K.F.; Chang, H.; Lee, A.S.; Ensser, A.; Wong, L.Y.; Toth, Z.; Lee, S.H.; Lee, H.R.; Myoung, J.; Ganem, D. et al. Construction and manipulation of a new Kaposi1s sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 2012, 86, 9708–9720. [CrossRef] [PubMed]
21. Myoung, J.; Ganem, D. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: Maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 2011, 174, 12–21. [CrossRef] [PubMed]
22. An, F.Q.; Folarin, H.M.; Compitello, N.; Roth, J.; Gerson, S.L.; McCrae, K.R.; Fakhari, F.D.; Dittmer, D.P.; Renne, R. Long-term-infected telomerase-immortalized endothelial cells: A model for Kaposi’s sarcomaassociated herpesvirus latency in vitro and in vivo. J. Virol. 2006, 80, 4833–4846. [CrossRef] [PubMed]
23. Tischer, B.K.; Kaufer, B.B. Viral bacterial artificial chromosomes: Generation, mutagenesis, and removal of mini-F sequences. J. Biomed. Biotechnol. 2012. [CrossRef] [PubMed]
24. Tischer, B.K.; von Einem, J.; Kaufer, B.; Osterrieder, N. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 2006, 40, 191–197. [PubMed]
25. Gandy, S.Z.; Linnstaedt, S.D.; Muralidhar, S.; Cashman, K.A.; Rosenthal, L.J.; Casey, J.L. RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol. 2007, 81, 13544–13551. [CrossRef] [PubMed]
26. Hu, J.; Yang, Y.; Turner, P.C.; Jain, V.; McIntyre, L.M.; Renne, R. LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex. PLoS Pathog. 2014, 10, e1004240. [CrossRef] [PubMed]
27. Cannon, J.S.; Ciufo, D.; Hawkins, A.L.; Griffin, C.A.; Borowitz, M.J.; Hayward, G.S.; Ambinder, R.F. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi1s sarcoma herpesviruscontaining supernatant. J. Virol. 2000, 74, 10187–10193. [CrossRef] [PubMed]
28. Yakushko, Y.; Hackmann, C.; Gunther, T.; Ruckert, J.; Henke, M.; Koste, L.; Alkharsah, K.; Bohne, J.; Grundhoff, A.; Schulz, T.F. et al. Kaposi1s sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J. Virol. 2010, 85, 4612–4617. [CrossRef] [PubMed]
29. Herndier, B.G.; Werner, A.; Arnstein, P.; Abbey, N. W.; Demartis, F.; Cohen, R.L.; Shuman, M.A.; Levy, J.A. Characterization of a human Kaposi’s sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994, 8, 575–581. [CrossRef] [PubMed]
30. Sturzl, M.; Gaus, D.; Dirks, W.G.; Ganem, D.; Jochmann, R. Kaposi1s sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line. Int. J. Cancer 2013, 132, 1954–1958. [CrossRef] [PubMed]
31. Contrant, M.; Fender, A.; Chane-Woon-Ming, B.; Randrianjafy, R.; Vivet-Boudou, V.; Richer, D.; Pfeffer, S. Importance of the RNA secondary structure for the relative accumulation of clustered viral microRNAs. Nucleic Acids Res. 2014, 42, 7981–7996. [CrossRef] [PubMed]
32. O’Hara, A.J.; Chugh, P.; Wang, L.; Netto, E.M.; Luz, E.; Harrington, W.J.; Dezube, B.J.; Damania, B.; Dittmer, D.P. Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog. 2009, 5, e1000389. [CrossRef] [PubMed]
33. Botto, S.; Totonchy, J.E.; Gustin, J.K.; Moses, A.V. Kaposi sarcoma herpesvirus induces HO-1 during de Novo infection of endothelial cells via viral miRNA-dependent and-independent mechanisms. mBio 2015, 6. [CrossRef] [PubMed]
34. Hu, M.; Wang, C.; Li, W.; Lu, W.; Bai, Z.; Qin, D.; Yan, Q.; Zhu, J.; Krueger, B.J.; Renne, R.; Gao, S.J.; Lu, C. A KSHV microRNA directly targets G protein-coupled receptor kinase 2 to promote the migration and invasion of Endothelial cells by inducing CXCR2 and activating AKT signaling. PLoS Pathog. 2015, 11, e1005171. [CrossRef] [PubMed]
35. Lee, M.-S.; Yuan, H.; Jeon, H.; Zhu, Y.; Yoo, S.; Shi, S.; Krueger, B.; Renne, R.; Lu, C.; Jung, J.U. et al. Human mesenchymal stem cells of diverse origins support KSHV persistent infection, and manifest distinct angiogenic, invasive and transforming phenotypes. mBio 2016, 7. [CrossRef] [PubMed]
36. Choi, H.S.; Jain, V.; Krueger, B.; Marshall, V.; Kim, C.H.; Shisler, J.L.; Whitby, D.; Renne, R. Kaposi1s sarcoma-associated herpesvirus (KSHV) induces the oncogenic miR-17–92 cluster and down-regulates TGF-β signaling. PLoS Pathog. 2015, 11, e1005255.
37. Kieffer-Kwon, P.; Happel, C.; Uldrick, T.S.; Ramalingam, D.; Ziegelbauer, J.M. KSHV microRNAs repress tropomyosin 1 and increase anchorage-independent growth and Endothelial tube formation. PLoS ONE 2015, 10, e0135560. [CrossRef] [PubMed]
38. Plaisance-Bonstaff, K.; Choi, H.S.; Beals, T.; Krueger, B.J.; Boss, I. W.; Gay, L.A.; Haecker, I.; Hu, J.; Renne, R. KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors. Viruses 2014, 6, 4005–4023. [CrossRef] [PubMed]
39. DiMaio, T.A.; Gutierrez, K.D.; Lagunoff, M. Kaposi1s sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation. J. Virol. 2014, 88, 14301–14309. [CrossRef] [PubMed]